Please provide your email address to receive an email when new articles are posted on . Within the baricitinib group, patients experienced a mean Vitiligo Area Scoring Index score change of 44.8% from ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Baricitinib preserved C-peptide levels and lowered ...

The effects of the JAK inhibitor baricitinib (Olumiant) waned after treatment was stopped among patients with new-onset type 1 diabetes, 2-year data from the phase II BANDIT trial showed. After ...

Baricitinib can effectively treat polymyalgia rheumatica (PMR) without the use of oral glucocorticoids, according to results from a small, randomized, double-blind, placebo-controlled study. Among the ...

Baricitinib demonstrated significant efficacy in severe alopecia areata, with over 50% achieving substantial hair regrowth within a year. Early intervention and patient selection, particularly those ...